Table 3 Relation between reported anxiety and depression and type of administered vaccine (n = 219)
Type of vaccine received | Total score anxiety | Total score depression | ||
|---|---|---|---|---|
Normal (0–7) (n = 106) | Abnormal (8–21) (n = 113) | Normal (0–7) (n = 122) | Abnormal (8–21) (n = 97) | |
Sinopharm (n = 69) | 42 (39.6%) | 27 (23.9%) | 48 (39.3%) | 21 (21.6%) |
AstraZeneca (n = 46) | 12 (11.3%) | 34 (30.1%) | 22 (18%) | 24 (24.7%) |
Pfizer–BioNTech (n = 104) | 52 (49.1%) | 52 (46%) | 52 (42.6%) | 52 (53.6%) |
P | 0.001* | 0.012* | ||